Kaiser G - Search Results

1

The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride.

Kaiser G, Ackermann R, Gschwind HP, James IM, Sprengers D, McIntyre N, Defalco A, Holmes IB. Kaiser G, et al. Biopharm Drug Dispos. 1990 Dec;11(9):753-64. doi: 10.1002/bdd.2510110903. Biopharm Drug Dispos. 1990. PMID: 2271751

2

Pharmacokinetics of the antidepressant levoprotiline after intravenous and peroral administration in healthy volunteers.

Kaiser G, Ackermann R, Dieterle W, Reimann IW, Bieck PR. Kaiser G, et al. Biopharm Drug Dispos. 1992 Mar;13(2):83-93. doi: 10.1002/bdd.2510130203. Biopharm Drug Dispos. 1992. PMID: 1550911 Clinical Trial.

3

Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly.

Kaiser G, Ackermann R, Dieterle W, Durnin CJ, McEwen J, Ghose K, Richens A, Holmes IB. Kaiser G, et al. Eur J Clin Pharmacol. 1990;38(4):379-85. doi: 10.1007/BF00315579. Eur J Clin Pharmacol. 1990. PMID: 2344861

4

Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration.

Kaiser G, Ackermann R, Brechbühler S, Dieterle W. Kaiser G, et al. Biopharm Drug Dispos. 1989 Jul-Aug;10(4):365-76. doi: 10.1002/bdd.2510100404. Biopharm Drug Dispos. 1989. PMID: 2758102

5

Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations.

Kaiser G, Ackermann R, Sioufi A. Kaiser G, et al. Am Heart J. 1989 Mar;117(3):746-51. doi: 10.1016/0002-8703(89)90765-5. Am Heart J. 1989. PMID: 2919553

6

The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.

Waldmeier F, Kaiser G, Ackermann R, Faigle JW, Wagner J, Barner A, Lasseter KC. Waldmeier F, et al. Among authors: kaiser g. Xenobiotica. 1991 Feb;21(2):251-61. doi: 10.3109/00498259109039467. Xenobiotica. 1991. PMID: 2058180

7

Determination of the new aromatase inhibitor CGS 16 949 in biological fluids by capillary gas chromatography/mass spectrometry.

Ackermann R, Kaiser G. Ackermann R, et al. Among authors: kaiser g. Biomed Environ Mass Spectrom. 1989 Aug;18(8):558-62. doi: 10.1002/bms.1200180808. Biomed Environ Mass Spectrom. 1989. PMID: 2529933

8

Determination of a new angiotensin converting enzyme inhibitor and its active metabolite in plasma and urine by gas chromatography-mass spectrometry.

Kaiser G, Ackermann R, Dieterle W, Dubois JP. Kaiser G, et al. J Chromatogr. 1987 Aug 7;419:123-33. doi: 10.1016/0378-4347(87)80272-4. J Chromatogr. 1987. PMID: 3667772

9

Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers.

De Lepeleire I, Van Hecken A, Verbesselt R, Kaiser G, Barner A, Holmes I, De Schepper PJ. De Lepeleire I, et al. Among authors: kaiser g. Eur J Clin Pharmacol. 1988;34(5):465-8. doi: 10.1007/BF01046703. Eur J Clin Pharmacol. 1988. PMID: 3203706 Clinical Trial.

10

Determination of the antidepressant levoprotiline and its N-desmethyl metabolite in biological fluids by gas chromatography/mass spectrometry.

Ackermann R, Kaiser G, Schueller F, Dieterle W. Ackermann R, et al. Among authors: kaiser g. Biol Mass Spectrom. 1991 Nov;20(11):709-16. doi: 10.1002/bms.1200201110. Biol Mass Spectrom. 1991. PMID: 1799582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters